News | April 28, 2024
Evonik expands capacity for customized Resomer powder biomaterials
New solvent-free micronization technology expanded at the Darmstadt site in Germany
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The collaboration focuses on the development and sharing of Standard Quality and Regulatory Documentation (StaQRD), a standard guide for the electronic transfer of information
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
Subscribe To Our Newsletter & Stay Updated
